Protection from sars-cov-2 variants by mvas expressing matched or mismatched s administered intranasally to mice

HIGHLIGHTS

• who: Catherine A. Cotter from the making it possible to directly compare experiments in different figuresVaccination A total of , u00d7 , PFU of rMVA in phosphate buffered saline and, .05% bovine serum albumin was injected in two , u00b5l aliquots IM into each hind leg of the mouse. For IN vaccination, mice were lightly sedated with isoflurane and , u00d7 , PFU of rMVA in , u00b5l was administered into one nostril. Infection with SARS-Co, SARS-Co, USA have published the research: Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice, in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.